why choose us

Clinical Trials Search

Showing 20,730 of 132,963 result(s)
iBCI Optimization for Veterans With Paralysis

Status: NOT_YET_RECRUITING

Condition: Spinal Cord Injury

Interventions: An embedded neural signal processor device will be evaluated for its ability to provide accurate and reliable closed-loop control in a home-based brai

Date: 2022-07-18

Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With BRCA1;2 Gene Alterations

Status: Completed

Condition: Prostate Cancer

Interventions: 300 mg orally twice a day (D1-D30) for 6 Cycles (30 day Cycles)

Date: 2022-07-18

PMCFU of an Annular Closure System

Status: Completed

Condition: Lumbar Disc Herniation

Interventions: Lumbar discectomy patients treated with Annular Closure Device BARRICAID

Date: 2022-07-18

Prostate Stimulation for Sexual Dysfunction

Status: NOT_YET_RECRUITING

Condition: Sexual Dysfunction

Interventions: Prostate stimulation device for sexual dysfunction

Date: 2022-07-18

Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes

Status: Completed

Condition: Gestational Diabetes

Interventions: 10 microgram injected sub-cutaneously once

Date: 2022-07-18

Effects of Immulina TM Supplements With PASC Patients

Status: Completed

Condition: Post Acute COVID-19 Syndrome

Interventions: Immulina TM is a highly standardized extract derived from various preparations of Spirulina, a cyanobacterium, marketed as a dietary supplement and ha

Date: 2022-07-18

Optimizing Digital Health Technology Interventions to Increase Skill Acquisition and Utilization

Status: Completed

Condition: Bulimia Nervosa

Interventions: Standard behavioral therapy for eating disorders aimed at changing behaviors that maintain binge eating (e.g.
rigid dietary restriction outside o

Date: 2022-07-18

Educational Video for Genetic Testing

Status: Completed

Condition: Genetic Disease

Interventions: We will develop an informational video to be presented within one week of diagnosis of a tumor to those referred for tumor normal paired genetic testi

Date: 2022-07-18

Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer

Status: Completed

Condition: Castration-resistant Prostate Cancer

Interventions: 40 mg taken orally

Date: 2022-07-18

Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma

Status: Completed

Condition: High Grade Astrocytic Tumor

Interventions: Correlative studies

Date: 2022-07-18